Peptide Purification Process Development Thiab Scale -Up
Peptide kev kho mob, vim lawv lub hom phiaj muaj peev xwm thiab muaj kev nyab xeeb siab, tau dhau los ua cov kev kho mob tseem ceeb rau cov kab mob xws li ntshav qab zib thiab mob qog noj ntshav. Txawm li cas los xij, cov impurities nyuaj tsim los ntawm kev sib xyaw ua ke -xws li peptides truncated, deletion variants, thiab oxidized khoom- ua rau muaj teeb meem loj rau cov txheej txheem purification. Daim ntawv tshaj tawm no qhia txog txoj hauv kev los tsim cov peptide purification workflows, cov tswv yim rau kev ua kom zoo dua qub, thiab cov txheej txheem rau kev teev- nce. Los ntawm kev tshuaj xyuas peb tus neeg sawv cev-GLP-1 analogs, antitumor cyclic peptides, thiab ultra-ntev peptides (60 amino acids)- nws muab kev tshuaj xyuas qhov tob ntawm cov teeb meem tseem ceeb thiab cov kev daws teeb meem hauv kev txhim kho txheej txheem, muab kev qhia dav dav rau kev lag luam ntawm peptide.
1. Cov txheej txheem tsim cov txheej txheem Peptide Purification
1.1 Kev soj ntsuam ntawm Lub Hom Phiaj Peptide yam ntxwv
Amino acid sequence: Hydrophobicity (piv txwv li, hauv semaglutide, Phe ntawm txoj haujlwm 6 thiab 23, Leu ntawm txoj haujlwm 14 thiab 26, Val ntawm txoj haujlwm 10 thiab 30, Ile ntawm txoj hauj lwm 24, Ala ntawm txoj hauj lwm 18 thiab 25, Trp ntawm txoj hauj lwm 27, Tyrose ntawm txoj hauj lwm 11} whole hydrophobicity-thiab -aminoisobutyric acid (Aib) ntawm txoj hauj lwm 2, uas yog ib qho tsis yog{18}}proteinogenic amino acid nrog siab hydrophobicity). Tsis tas li ntawd, semaglutide muaj 17-carbon fatty diacid sab saw txuas rau lysine residue ntawm txoj hauj lwm 26; Qhov kev hloov kho hydrophobic no yog qhov tseem ceeb ntawm cov qauv ua kom muaj albumin khi thiab ntev - ua haujlwm. Kev faib tawm (qhov sib piv ntawm cov acidic / hauv paus residues, piv txwv li, tag nrho cov amino acid sequence ntawm semaglutide yog: His-Aib-Glu-Gly-Thr-Ph-Thr-Ser{-Asp-Val-Ser-Ser-Tyr-Leu-Glu{{38} }Gly-Gln-Ala-Ala-Lys-Glu-Ph-Ile -Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly, Qhov sib piv ntawm acidic rau cov amino acids yog 1: 1). Tsis tas li ntawd, semaglutide yog ib leeg-chain peptide uas tsis muaj disulfide bonds hauv nws cov qauv.
Molecular hnyav: Qhov no cuam tshuam rau kev xaiv ntawm chromatography txhua kab thiab daim nyias nyias (piv txwv li, kev sib cais ntau ntawm SEC thiab khaws cia / permeation ntau ntawm UF / DF membranes). Piv txwv li, cov qauv tshuaj ntawm semaglutide yog C₁₈₇H₂₉₁N₄₅O₅₉, muab cov lej ntsuas molecular ntawm 4113.6 Da. Thaum lub sij hawm SEC sib cais ntawm semaglutide, Seplife G-25 chromatography resin tuaj yeem xaiv, thiab rau kev sib xyaw thiab tsis sib pauv, 1 kDa membrane module tuaj yeem siv.
Stability: rhiab heev rau pH, kub, thiab oxidative tej yam kev mob. Piv txwv li, semaglutide muaj pI ntawm 5.4, thiab nws cov degradation kuj siab ntawm pH 4.5-5.5, uas nyob ze nws pI, thaum nws tseem nyob ruaj khov nyob rau hauv lwm yam pH tsis.
Case Reference: Semaglutide (31 amino acids) muaj Gln residues, uas yuav tsum tsis txhob deamidation nyob rau hauv qis pH. Cov pab pawg amide (-CONH₂) ntawm Gln sab saw tuaj yeem raug hydrolysis nyob rau hauv cov xwm txheej tshwj xeeb (xws li acidic lossis ib puag ncig yooj yim, lossis enzyme- catalyzed cov tshuaj tiv thaiv), hloov mus rau qhov tsis zoo glutamic acid (Glu) residues (-COOH). Cov tshuaj tiv thaiv no tuaj yeem hloov pauv cov protein cov nqi faib khoom, kev sib haum xeeb, thiab kev ua haujlwm zoo. Deamidation ntawm glutamine (Gln) pawg nyob rau hauv qis pH (acidic tej yam kev mob, pH <5) yog ib tug tshuaj cov tshuaj tiv thaiv nyob rau hauv uas cov amide pawg (-CONH₂) ntawm Gln sab saw yog hydrolyzed los ua carboxyl pawg (-COOH) ntawm Glu, tso ammonia (NH₂) Yog li ntawd, acidic tej yam kev mob yuav tsum tau zam thaum lub sij hawm purification thiab cia ntawm semaglutide.
1.2 Kev soj ntsuam ntawm Impurity Profile thiab Tswj Lub Hom Phiaj
Synthetic impurities:truncated peptides (tsis muaj 1-2 amino acids), tshem tawm peptides (ib ntu ua yuam kev), thiab cov pab pawg tiv thaiv seem. Ib ntus-txog impurities feem ntau raug tshem tawm siv thim rov qab-theem chromatography.
Folding impurities:Feem ntau peptides muaj ib txoj hlua khi thiab tsis tas yuav folding. Folding-txog impurities feem ntau tshwm sim hauv kev npaj cov protein, xws li disulfide bond mispairing.
Txheej txheem -Txog impurities:hlau catalysts (palladium, nickel) thiab residual organic solvents.
Tswj Cov Cai:Purity Ntau dua los yog sib npaug rau 98% (HPLC), ib qho impurity Tsawg dua lossis sib npaug li 0.5%, hlau residues Tsawg dua lossis sib npaug rau 10 ppm (ICH Q3D). Khoom-txog impurities ntawm semaglutide suav nrog aggregates, degradation cov khoom, hloov kho-/conjugation-txog impurities, stereoisomers ntawm asymmetric carbons, hloov variants (xws li, methionine oxidation, aspartic acid deamidation/isomerducttes), intermediate, 1. Rau cov khoom uas qhia los ntawm cov poov xab fermentation, ntxiv post- kev hloov kev txhais lus xws li methylation, acetylation, thiab glycosylation tej zaum yuav tshwm sim, manifesting macroscopically raws li molecular loj variants, nqi variants, thiab glycoform heterogeneity.
1.3 Kev xaiv ntawm Purification Platform Technology
|
Tshuab |
Siv tau Scenarios |
Kev daws teeb meem |
flux ua |
nqi |
|
Rov qab -Phase Chromatography (RPC) |
Peptides nrog qhov sib txawv hydrophobic tseem ceeb |
siab |
nruab nrab |
siab |
|
Ion Txauv (IEX) |
Them peptides (piv txwv li, muaj Lys, Arg) |
nruab nrab |
siab |
nruab nrab |
|
Gel Filtration (SEC) |
Tshem tawm ntawm dimers / degradation fragments |
qis |
qis |
qis |
|
Hydrophobic Interaction Chromatography (HIC) |
Peptides uas muaj ntxhiab amino acids |
nruab nrab |
nruab nrab |
siab |
2. Txheej Txheem Kev Txhim Kho Kev Ua Haujlwm thiab cov kauj ruam tseem ceeb
Crude Material Pretreatment
Kev xaiv ntawm Dissolution Buffer:Kev xaiv ntawm purification txoj kev tom qab dissolving cov khoom crude yuav tsum coj cov kev xaiv ntawm dissolution tsis. Kev sib raug zoo ntawm qhov kev sib cais tsis sib haum thiab cov txheej txheem purification tom ntej yuav tsum raug txiav txim siab kom tsis txhob muaj kev sib pauv tsis sib xws. Piv txwv li, semaglutide tuaj yeem yaj hauv 0.1% TFA / acetonitrile rau RPC, lossis hauv 20 mM Tris-HCl, pH 8.0 rau IEX.
Sterile Filtration:0.22 μm lim membrane yog siv los tshem tawm cov khoom thiab tiv thaiv kab mob. Cov ntsiab cai ntawm kev ncaj qha - siab pom thiab TFF (tangential flow filtration) txawv. Thaum xaiv ib chav lim membrane, cov yam ntxwv xws li membrane flux, khaws cia ntau yam, cov khoom siv, thiab qhov ntim qhov system tuag yuav tsum raug txiav txim siab. Rau sterile filtration, 0.22 μm ncaj qha - lim lim yog feem ntau xaiv, whereas kom paub meej, 0.1-0.22 μm TFF membranes los yog ib tug series ntawm daim nyias nyias nrog txawv pore ntau thiab tsawg yog feem ntau siv nyob rau hauv stepwise pom. Xwb, ua ke ntawm daim nyias nyias nrog ntau qhov pore qhov ntau thiab tsawg, xws li cov ntxaij lim dej tob, kuj tuaj yeem ua haujlwm.
Chromatography Kem Screening
Resin/Stationary Phase Hom:Silica C18 (siab loading peev), Silica C8 (kev sib cais ceev), polymer-raws li matrices (alkali{3}}resistant, xws li, polystyrene microsphere thim rov qab-theem resins).
2.1 Ion Txauv Chromatography (IEX)
Kem Dimensions:Laboratory nplai (4.6 × 250 mm), ntau lawm nplai (50 × 500 mm).
Gradient optimization:
Acetonitrile Gradient ntau yam:Teem sijhawm raws li peptide tuav lub sijhawm (piv txwv li, 20% -50%).
Gradient txoj kab nqes:Txoj kab nqes ntiav (0.5% / min) txhim kho kev daws teeb meem, thaum txoj kab nqes qis (2% / min) ua kom lub sijhawm khiav.
Lub hauv paus rau kev xaiv cov txheej txheem huv thiab kev sib piv
3.1 Cov txiaj ntsig tseem ceeb ntawm Reversed-Phase Chromatography (RP-HPLC)
Kev daws teeb meem siab:Muaj peev xwm cais impurities nrog molecular hnyav sib txawv me me li 1 Da (xws li, deamidation khoom).
Kev siv dav dav:Haum rau ntau tshaj 80% ntawm cov peptides hluavtaws.
3.2 Cov Kev Siv Tshwj Xeeb ntawm Ion Txauv (IEX)
Tus nqi -Kev sib cais nyob ntawm:Peptides nrog cov khoom sib txawv yog sib cais siv pH gradient elution (piv txwv li, pH 4.0 → 7.0).
3.3 Multidimensional Chromatography
RP-IEX Kev sib xyaw ua ke:Peptides yog thawj zaug purified los ntawm IEX kom tshem tawm cov impurities them, ua raws li RP-HPLC rau polishing zaum kawg. Qhov no yog tam sim no siv dav tshaj plaws thiab tseem ceeb tshaj plaws rau kev ua kom huv peptide, feem ntau siv rau peptides xws li insulin thiab GLP-1R analogs.
4. Txheej txheem txheej txheem optimization tswv yim
4.1 Mobile Phase Composition Optimization
Kev Xaiv Ntxiv:
0.1% TFA:Txhim kho lub ncov zoo thiab suppresses silanol kev sib cuam tshuam.
10 mM NH₄HCO₃:Nws tuaj yeem siv los ua TFA lwm txoj hauv kev los txo cov kev cuam tshuam hauv huab hwm coj spectrometry.
Gradient Design:
Stepwise Gradient:Siv 20%–30% (10 min) → 30%–40% (40 min) tuaj yeem txhim kho cov txiaj ntsig.

4.3 Kev txheeb xyuas qhov xwm txheej
UV Detection Wavelengths:214 nm (peptide bond absorption), 280 nm (Trp / Tyr).
5. Scale-Tau los ntawm Laboratory mus rau ntau lawm
5.1 Linear Scale-Up
Tom qab ua tiav kev tsim cov txheej txheem me me - ntsuas qhov ntsuas kom huv, cov txheej txheem tau faib ua feem hauv qhov chaw tsim khoom tsis yog -piv txwv li, pilot plant). Lub hom phiaj yog txhawm rau txheeb xyuas qhov ua tau, ruaj khov, thiab rov ua dua ntawm cov txheej txheem, tso lub hauv paus rau kev lag luam tom ntej. Lub hauv paus tseem ceeb ntawm cov txheej txheem no yog los daws cov teeb meem tshiab uas tshwm sim los ntawm qhov ntsuas - nce, xws li cov cuab yeej siv tau zoo, kev hloov pauv hauv kev ua haujlwm (xws li, kub, siab, ntws tus nqi), qhov sib txawv ntawm kev hloov pauv huab cua, thiab batch- mus rau -batch sib xws tswj.
Kem Diameter Scale-Up:Scale raws li tus ntoo khaub lig-sectional cheeb tsam (piv txwv li, 4.6 mm → 50 mm, scale factor ≈ 118 ×).
Flow Rate Kho:Tswj cov kab khiav tawm (piv txwv li, 1 mL / min → 50 mL / min).
Gradient Extension:Txuas lub sij hawm gradient proportionally rau sab ntim (piv txwv li, 60 min → 300 min)
5.2 Kev tsim khoom-Kev xaiv cov khoom siv nplai
Dynamic Axial Compression Columns (DAC):Haum rau reversed-theem resins, polystyrene me me-particle (10–15 µm) ion exchange resins, thiab polymer-raws li hydrophobic resins. Nyob rau hauv sib piv, qis- siab iav chromatography kab yog ntau haum rau agarose hlaws resins thiab yog dav siv nyob rau hauv recombinant peptide capture theem.
Xaus
Peptide purification txheej txheem yuav tsum tsom mus rau lub hom phiaj molecule tus yam ntxwv, ua kom muaj kev sib cais los ntawm ntau qhov chaw chromatography, ntse parameter optimization, thiab cov cuab yeej tshiab. Peb qhov kev tshawb fawb loj qhia tau hais tias kev nce qib los ntawm kev txhim kho mus rau kev tsim khoom yuav tsum sib npaug ntawm kev tshawb fawb nruj nrog kev xav txog engineering. Yav tom ntej technologies yuav tsum evolve mus rau tas mus li, ntse, thiab ntsuab txheej txheem.







